Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

187

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A16AB04	FABRAZYME	BioTech	Agalsidase beta - 35mg	35mg	Injectable powder for concentrate for solution	295,038,213 L.L
P02CA03	ALBENDA	G	Albendazole - 100mg/5ml	400mg/20ml	Suspension	129,009 L.L
P02CA03	ALBENDA	G	Albendazole - 200mg	200mg	Tablet	116,914 L.L
P02CA03	ALBENDAZOLE-UBSA	G	Albendazole - 200mg	200mg	Tablet	127,985 L.L
P02CA03	ANDAZOL	G	Albendazole - 200mg	6	Tablet, film coated	302,365 L.L
P02CA03	ZENTEL	B	Albendazole - 400mg	400mg	Tablet	169,324 L.L
B05AA01	YDRALBUM 200G/L	BioHuman	Albumin human - 10g/50ml		Injectable solution	3,417,391 L.L
B05AA01	ALBUKEY	BioHuman	Albumin human - 20%	20%	Injectable solution	4,863,366 L.L
B05AA01	ALBUREL HUMAN ALBUMIN BP	BioHuman	Albumin human - 20%	20%	Injectable solution	3,240,004 L.L
B05AA01	ALBUREL HUMAN ALBUMIN BP	BioHuman	Albumin human - 20%	20%	Injectable solution	6,353,687 L.L
B05AA01	ALBUTEIN	BioHuman	Albumin human - 20%	20%	Injectable solution	7,154,928 L.L
B05AA01	ALBUTEIN	BioHuman	Albumin human - 20%		Injectable solution	4,031,528 L.L
B05AA01	HUMAN ALBUMIN "OCTAPHARMA" 20%	BioHuman	Albumin human - 20%	20%	Injectable solution	4,863,366 L.L
B05AA01	HUMAN ALBUMIN 20% SOLUTION	BioHuman	Albumin human - 20%	20%	Injectable solution	4,343,343 L.L
B05AA01	HUMAN ALBUMIN BEHRING 20%, LOW SALT	BioHuman	Albumin human - 20%	20%	Injectable solution	4,343,343 L.L
B05AA01	PLASBUMIN-20 ALBUMIN (HUMAN)	BioHuman	Albumin human - 20%	20%	Injectable solution	3,641,813 L.L
B05AA01	ALBUREL HUMAN ALBUMIN BP	BioHuman	Albumin human - 20%	20%	Injectable solution	L.L
B05AA01	VIALEBEX	BioHuman	Albumin human - 200g/L	200g/L	Injectable solution	3,417,391 L.L
B05AA01	UMAN ALBUMIN	BioHuman	Albumin human - 20g/100ml	10g/50ml	Injectable solution	3,598,810 L.L
L01ED03	ALECENSA	B	Alectinib - 150mg	150mg	Capsule, hard	490,837,809 L.L
L01ED03	ALECENSA	B	Alectinib - 150mg	150mg	Capsule, hard	L.L
M05BA04	APO-ALENDRONATE	G	Alendronate (monosodium trihydrate) - 70mg	70mg	Tablet	981,005 L.L
M05BA04	MARVIL 70	G	Alendronate (monosodium trihydrate) - 70mg	70mg	Tablet, coated	1,173,175 L.L
M05BA04	FOSAMAX 70MG ONCE WEEKLY	B	Alendronate - 70mg	70mg	Tablet	1,988,887 L.L
M05BA04	OREK	G	Alendronate - 70mg	70mg	Tablet, coated	2,404,838 L.L
M05BA04	STRONDEX 70	G	Alendronate sodium - 70mg	70mg	Tablet	1,305,447 L.L
M05BA04	BINOSTO	B	Alendronate sodium - 70mg	70mg	Tablet, effervescent	1,709,368 L.L
M05BA04	OSTEOMED	G	Alendronic acid (sodium alendronate) - 70mg	70mg	Tablet, scored	950,929 L.L
M05BB03	FOSAVANCE	B	Alendronic acid (sodium alendronate) - 70mg, Colecalciferol - 5600IU		Tablet	1,988,887 L.L
M05BB03	ACIDE ALENDRONIQUE/ VITAMINE D3 BGR	G	Alendronic acid - 70mg, Colecalciferol - 5600UI		Tablet	815,712 L.L

...

187